Mucinous Adenocarcinoma

This is a type of cancer that starts in the cells that make up glands and produces a lot of mucus. It's a specific subtype of adenocarcinoma.

Condition

What people with Mucinous Adenocarcinoma report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Mucinous Adenocarcinoma

What It Is

Mucinous adenocarcinoma is a type of cancer that starts in the gland cells lining certain internal organs and produces large amounts of mucin, the main ingredient of mucus. Under the microscope, clusters of cancer cells appear to float in pools of this mucus. The name, also written as mucinous or colloid carcinoma, describes what the tumor looks like rather than where it is. That distinction matters because mucinous adenocarcinoma is a subtype of a cancer in a particular organ, and its behavior depends largely on that organ. It is best known in the colon and rectum, where it makes up roughly 10 to 15 percent of colorectal cancers. It also occurs in the breast, lung, ovary and appendix. A mucinous breast cancer, for example, often grows slowly and has a favorable outlook, while a mucinous rectal cancer tends to be harder to treat than the usual form. Anyone with this diagnosis is best served by information about their specific organ and stage.

Causes & Risk Factors

No cause specific to the mucinous type has been established. The risk factors are generally those of cancer in the affected organ. For colorectal cancer, these include older age, a personal or family history of colorectal cancer or precancerous polyps, long-standing ulcerative colitis or Crohn's disease, smoking, heavy drinking and obesity. Inherited conditions such as Lynch syndrome also raise colorectal cancer risk. Some patterns are specific to the mucinous form. In the colon, it is found more often on the right side and tends to carry particular genetic changes in the tumor, including one called microsatellite instability, a defect in how tumor cells repair their DNA. People with the mucinous type of lung cancer are more likely to have never smoked than people with other lung cancers, though smoking remains a risk factor for lung cancer overall. These are features of the tumor, not evidence that a person did something to cause it.

How It's Diagnosed

The diagnosis is made by a pathologist examining tumor tissue under a microscope, usually from a biopsy or from the tumor removed at surgery. In colorectal cancer, a tumor is called mucinous adenocarcinoma when mucin makes up more than half of it. A tumor with a smaller but significant amount of mucin, roughly 10 to 50 percent, is described as having mucinous features instead. Because a small biopsy may not capture the whole tumor, the final label sometimes changes after surgery. Mucin-rich tumors can also look distinctive on scans; for rectal cancer, an MRI (magnetic resonance imaging) scan often identifies the mucinous type more accurately than an initial biopsy. Further imaging shows how far the cancer has spread, which guides treatment. The tumor tissue is usually also tested for specific changes. In colorectal cancer, this includes microsatellite instability (MSI), a defect in how cells repair their DNA. Mucinous tumors have it more often than other colorectal cancers, and it affects whether immunotherapy is an option. An MSI result can also prompt testing for an inherited condition such as Lynch syndrome, although most such results are not inherited, and genetic counseling helps sort this out. For a mucinous tumor found in the ovary, doctors also check whether it began there or spread from the digestive tract, since the treatment differs.

Treatment Options

Treatment follows the standard approach for cancer of the affected organ and stage, adjusted for how the mucinous type behaves. Surgery to remove the tumor is the main treatment when the cancer is confined to one area. In colon cancer, chemotherapy after surgery is standard for stage III tumors, which have reached nearby lymph nodes. For stage II tumors, which have grown deep into or through the bowel wall without reaching lymph nodes, it is considered case by case depending on risk features and microsatellite status. Stage II tumors with microsatellite instability often do not need it. Mucinous cancers also tend to respond less well to chemotherapy in advanced stages. In rectal cancer, radiation and chemotherapy given before surgery shrink mucinous tumors less often, so doctors are more cautious about a watch-and-wait approach that skips surgery after a good response. Tumors with microsatellite instability can respond well to immunotherapy, medicines called immune checkpoint inhibitors that help the immune system recognize cancer cells. When mucinous cancer spreads to the lining of the abdomen, surgery to remove the visible deposits may be part of treatment in carefully selected people. In the breast, treatment usually centers on surgery (removing the lump or the whole breast) and, because most mucinous breast cancers are fueled by hormones, hormone-blocking therapy. Many people do not need chemotherapy. Mucinous ovarian cancer responds poorly to the standard platinum chemotherapy used for other ovarian cancers, so surgery is especially important. Mucinous tumors of the appendix that fill the abdomen with mucus, a condition called pseudomyxoma peritonei, are treated in specialized centers with extensive surgery plus chemotherapy delivered into the abdomen. In the lung, surgery offers the best results for localized disease; treatment for advanced mucinous lung cancer is still being refined.

What to Expect

Outlook varies more by organ and stage than by the mucinous label itself. Pure mucinous breast cancer usually has a favorable outlook, with a low rate of spread to lymph nodes and of recurrence. In colorectal cancer, mucinous tumors are more often found at a later stage, partly because their soft consistency means symptoms may not appear until the tumor is large. Studies disagree about whether colon mucinous cancer does worse than the usual type at the same stage, but most find a poorer outlook for mucinous rectal cancer. After treatment, follow-up involves regular visits and tests to watch for the cancer returning; how often and which tests depend on the organ and stage. Because colorectal mucinous cancer spreads to the lining of the abdomen more often than other types, follow-up may pay particular attention to that area. Treatment can be long and tiring, and recovery from bowel, breast or lung surgery takes time. Many people find it useful to be treated at, or get a second opinion from, a center that sees many cases of their specific cancer, particularly for rarer forms such as mucinous ovarian cancer or pseudomyxoma peritonei.

When to Seek Help

See a doctor about symptoms that could point to the cancers where this type is most common: blood in the stool, a change in bowel habits lasting more than a few days, unexplained weight loss, or a new lump or thickening in the breast or armpit. A pneumonia that does not improve with antibiotics or keeps returning in the same part of the lung, especially with a persistent cough producing large amounts of clear or white sputum, warrants further investigation rather than another round of the same treatment. After a diagnosis, contact the care team about new or worsening symptoms, such as growing abdominal swelling, or about side effects that make treatment hard to continue. Severe or worsening abdominal pain with repeated vomiting, a swollen belly, or being unable to pass stool or gas can signal a blocked bowel, which is an emergency: get medical care right away.

Questions to Ask Your Doctor

  1. 1.Where did my cancer start, what stage is it, and how does the mucinous type change my outlook compared with the usual form?
  2. 2.Has my tumor been tested for microsatellite instability or other changes that affect treatment, and do I need genetic counseling?
  3. 3.How well is my type expected to respond to chemotherapy or radiation, and what does that mean for the order of my treatments?
  4. 4.Should I get a second opinion at a center that treats many mucinous cancers like mine?
  5. 5.What will my follow-up involve, and which symptoms should I report between visits?

Last reviewed • Oct 2026

Educational content, not medical advice.